ARCHIVES

In Brief: Richard Fisher Named Physician-in-Chief, Executive Vice President at Fox Chase Cancer Center

This article is from The Cancer Letter archive.

Vol. 38 No. 45 | December 7, 2012

Download PDF Visit The Full Archive

Related Articles

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

FDA news: Von Eschenbach to FDA staff: “I did not come here to be a figurehead…. While I am here, I will lead.”

November 4, 2005

Reauthorization Still Held up

September 30, 1988

Workshop Calls For Improved Surgical Oncology Training Programs

December 2, 1983

Cancers Linked To Agent Orange In IOM Review

August 13, 1993

DCT Board Okays Bladder Cancer RFA From Organ Systems Program

June 6, 1986